APA (7th ed.) Citation

PC, K., G, D., M, D. F., A, L., T, V., A, M., . . . JS, L. (2026). Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 67(5), 765. https://doi.org/10.2967/jnumed.125.271098

Chicago Style (17th ed.) Citation

PC, Klauser, et al. "Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 67, no. 5 (2026): 765. https://doi.org/10.2967/jnumed.125.271098.

MLA (9th ed.) Citation

PC, Klauser, et al. "Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 67, no. 5, 2026, p. 765, https://doi.org/10.2967/jnumed.125.271098.